RNA, U6 small nuclear 312, pseudogene (RNU6-312P)

RNU6-312P is a human pseudogene derived from the U6 small nuclear RNA family[6]. U6 snRNA is a highly conserved and essential component of the spliceosome, the molecular complex responsible for intron removal in pre-mRNA[1][3]. Pseudogenes such as RNU6-312P result from gene duplication or retrotransposition events and generally do not produce functional RNA or protein products[2][5][6]. While some non-coding RNA pseudogenes have been shown to regulate protein-coding gene expression in rare cases[4], there is currently no evidence that RNU6-312P is functional or involved in disease processes, therapeutic mechanisms, or biomarker applications. Its primary significance is as a genomic sequence homologous to U6 snRNA, carrying sequence similarity but lacking an established biological, pathogenic, or therapeutic role[2][6][5]. In summary: RNU6-312P is a pseudogene similar to U6 small nuclear RNA, with no demonstrated biological function, disease involvement, or role as a therapeutic target. It is not considered relevant for drug discovery or as a clinical biomarker. The entry is structurally correct regarding gene annotation, but it does not meet the criteria for a molecular target in pharmacology or biomedical research.

Other names

RNU6-312PRNA, U6 small nuclear 312, pseudogene